Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Necroptosis: a crucial pathogenic mediator of human disease
Mary E. Choi, David R. Price, Stefan W. Ryter, Augustine M. K. Choi
Mary E. Choi, David R. Price, Stefan W. Ryter, Augustine M. K. Choi
View: Text | PDF
Review

Necroptosis: a crucial pathogenic mediator of human disease

  • Text
  • PDF
Abstract

Necroptosis is a genetically regulated form of necrotic cell death that has emerged as an important pathway in human disease. The necroptosis pathway is induced by a variety of signals, including death receptor ligands, and regulated by receptor-interacting protein kinases 1 and 3 (RIPK1 and RIPK3) and mixed-lineage kinase domain–like pseudokinase (MLKL), which form a regulatory necrosome complex. RIPK3-mediated phosphorylation of MLKL executes necroptosis. Recent studies, using animal models of tissue injury, have revealed that RIPK3 and MLKL are key effectors of injury propagation. This Review explores the functional roles of RIPK3 and MLKL as crucial pathogenic determinants and markers of disease progression and severity in experimental models of human disease, including acute and chronic pulmonary diseases; renal, hepatic, cardiovascular, and neurodegenerative diseases; cancer; and critical illness.

Authors

Mary E. Choi, David R. Price, Stefan W. Ryter, Augustine M. K. Choi

×

Figure 1

Modes of cell death.

Options: View larger image (or click on image) Download as PowerPoint
Modes of cell death.
Cell death pathways include those that are regulate...
Cell death pathways include those that are regulated by genetic programs, which are designated regulated cell death (RCD), and those that are not regulated, which are designated accidental cell death (ACD). Apoptosis is a form of RCD that requires activation of caspases, leading to DNA fragmentation. The initiation of apoptosis may be receptor dependent (extrinsic pathway) or triggered by injurious stimuli (intrinsic pathway), resulting in mitochondrial dysfunction. Apoptosis culminates in nonlytic cell death, which is noninflammatory. Pyroptosis is a form of lytic cell death that occurs in inflammatory cells in response to proinflammatory stimuli. A cardinal feature of pyroptosis is the requirement for inflammasome-dependent caspase-1 activation, which regulates the maturation and secretion of proinflammatory cytokines. Pyroptosis occurs as the result of gasdermin D–regulated (GSDMD-regulated) membranous pore formation and features cytoplasmic swelling and cytosolic content leakage. Necroptosis represents a form of RCD that is activated by RIPK1 and requires RIPK3-dependent phosphorylation of MLKL. MLKL oligomerization results in plasma membrane rupture, leading to a lytic form of cell death associated with release of DAMPs. Ferroptosis is an RCD mode that is distinct from necroptosis. In ferroptosis, iron-dependent lipid peroxidation causes lytic cell death, which can be inhibited by glutathione peroxidase 4 (GPX4). Necrosis is a lytic form of ACD that results in DAMP release and propagation of inflammation. A variant of necrosis that involves mitochondrial permeability transition (MPT) has also been described. DAMPs, damage-associated molecular patterns; MLKL, mixed-lineage kinase domain–like pseudokinase; NLRP3, nucleotide-binding oligomerization domain–, leucine rich repeat–, and pyrin domain–containing protein 3; PYCARD, PYRIN-PAAD-DAPIN domain– and C-terminal caspase-recruitment domain–containing protein; RIPK1, receptor-interacting protein kinase 1; RIPK3, receptor-interacting protein kinase 3.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts